找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Essentials of Operative Cardiac Surgery; Prakash P. Punjabi,Panagiotis G. Kyriazis Book 2022Latest edition Springer Nature Switzerland AG

[復(fù)制鏈接]
樓主: 選民
11#
發(fā)表于 2025-3-23 12:23:04 | 只看該作者
Minimally Invasive Mitral Valve Repair/Replacement,many expert mitral valve repair centers. The technique is safe and efficient and its superiority to conventional sternotomy has been demonstrated in terms of postoperative bleeding, ICU and length of hospital stays. Results of the technique still remain dependent on the surgeon mastering the techniq
12#
發(fā)表于 2025-3-23 15:33:58 | 只看該作者
13#
發(fā)表于 2025-3-23 21:40:21 | 只看該作者
Ascending Aortic Aneurysm Surgery,nd incidentally. If left untreated, aneurysms can continue to grow, leading to eventual rupture and death. Current guidelines suggest threshold of 5.5 cm for surgical intervention in the absence of risk factors, however, any predisposing genetic factors lower this threshold. The fundamental principl
14#
發(fā)表于 2025-3-23 23:43:25 | 只看該作者
Ascending Aortic Dissection Surgery,d most experienced centers. Patients can present with cardiac tamponade, stroke, myocardial infarction, acute aortic insufficiency, or malperfusion involving various arterial beds. The key principles of the surgical management of ascending aortic dissection are to resect the intimal tear, to reestab
15#
發(fā)表于 2025-3-24 05:25:23 | 只看該作者
16#
發(fā)表于 2025-3-24 06:38:10 | 只看該作者
Coronary Artery Bypass Graft vs. Percutaneous Intervention,(CABG) continues. This chapter’s first section identifies what criteria should be evaluated when deciding upon revascularization strategy, including: surgical mortality, anatomical considerations, and the ability to achieve complete revascularization. The second section of the chapter reviews curren
17#
發(fā)表于 2025-3-24 11:19:39 | 只看該作者
18#
發(fā)表于 2025-3-24 17:20:15 | 只看該作者
Till Alexander Backsmann,Carmen BacksmannSIRS. Emerging therapies aiming to inhibit the uncontrolled inflammatory response during CPB may provide clinical benefit and reverse adverse clinical outcomes. Clinical observations and level of evidence will be reviewed.
19#
發(fā)表于 2025-3-24 21:58:46 | 只看該作者
20#
發(fā)表于 2025-3-25 03:08:08 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 21:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
夹江县| 萍乡市| 牡丹江市| 济源市| 夏津县| 南部县| 贡嘎县| 迁安市| 遵义市| 马关县| 英吉沙县| 建宁县| 太仓市| 乌拉特前旗| 乾安县| 同仁县| 南溪县| 溆浦县| 鹤岗市| 青海省| 平阳县| 泽库县| 招远市| 东辽县| 革吉县| 上高县| 商南县| 安丘市| 永善县| 来凤县| 龙井市| 崇左市| 辽中县| 辰溪县| 华亭县| 万全县| 尚志市| 平湖市| 龙井市| 砀山县| 宜黄县|